New
Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →
Advertisement
Advertisement
RZGvsETF 2ETF Comparison
Choose a second ETF to run a side-by-side ETF comparison with RZG, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
RZG performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 03/12/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | RZG ETF 2 | -4.52%– | -0.63%– | +2.49%– | +21.63%– | +51.00%– | +6.84%– |
| Flows | RZG ETF 2 | -$584K– | -$1M– | -$35K– | -$14M– | -$18M– | -$39M– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | RZG ETF 2 | +17.53%– | +22.44%– | +20.35%– | +22.97%– |
| Max drawdown | RZG ETF 2 | -6.97%– | -14.71%– | -25.62%– | -38.45%– |
| Max drawdown duration | RZG ETF 2 | 14d– | 46d– | 296d– | 1521d– |
Trading data
RZG | ETF 2 | |
Last sale 3/12/2026 at 1:30 PM | $55.65 | – |
| Previous close 03/12/2026 | $57.04 | – |
| Consolidated volume 03/12/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of February 27, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
RZG | ETF 2 | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 3/12/2026 at 1:30 PM
Live
Closed
RZG | ETF 2 | |
|---|---|---|
| Last price | $55.65 | – |
| 1D performance | -2.44% | – |
| AuM | $105.85 M | – |
| E/R | 0.35% | – |
Characteristics
RZG | ETF 2 | |
|---|---|---|
| Management strategy | Passive | – |
| Provider | Invesco | – |
| Benchmark | S&P SmallCap 600 Pure Growth Index | – |
| N° of holdings | 120 | – |
| Asset class | Equities | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | March 1, 2006 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
RZG
USA
97.2%
Other
2.8%
ETF 2
Sectors
RZG
Health Care
22.74%
Industrials
17.89%
Information Techn.
16.26%
Financials
16.03%
Consumer Discreti.
8.68%
Other
18.4%
ETF 2
Advertisement
Diversification
RZG
Total weight of top 15 holdings out of 15
21.07%
ETF 2
–
Top 15 holdings
Data as of January 31, 2026
RZG
ACM RESEARCH
1.83%
PTC THERAPEUTI/D
1.58%
TRANSMEDICS GROUP
1.50%
PRIMORIS SERVICES
1.49%
US6496048405
1.47%
US0423157058
1.44%
ACADIA PHARMACEUTICALS
1.40%
PROGYNY INC
1.38%
ARROWHEAD PHARMACEUTICALS INC
1.37%
INTERDIGITAL
1.31%
BRIGHTSPHERE INVESTMENT GROUP
1.28%
PROTAGONIST THERAPEUTICS INC
1.28%
DXP ENTERPRISES
1.27%
COLLEGIUM PHAR/D
1.26%
ANI PHARMACEUTICALS INC
1.24%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
Advertisement
The Active Trader Report
Active Trader Report: Use of Leveraged & Inverse ETFs Way Up
Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.
